Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $44,634 - $52,382
-75 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$543.48 - $670.97 $16,304 - $20,129
30 Added 66.67%
75 $47,000
Q3 2021

Jan 12, 2022

BUY
$574.03 - $680.96 $25,831 - $30,643
45 New
45 $27,000
Q2 2021

Sep 01, 2021

SELL
$472.8 - $558.54 $20,330 - $24,017
-43 Closed
0 $0
Q4 2020

Mar 24, 2021

BUY
$478.3 - $607.98 $20,566 - $26,143
43 New
43 $21,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $99.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Iron Bridge Private Wealth, LLC Portfolio

Follow Iron Bridge Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Bridge Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Bridge Private Wealth, LLC with notifications on news.